
Rachael G. Pontikes
FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B
Health Industry Washington Watch ·
FDA publishes new draft guidance on animal drug compounding
Life Sciences Legal Update ·